bromocriptine has been researched along with Ovarian Hyperstimulation Syndrome in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Bu, X; Jia, C; Liu, Y; Ma, Y; Wang, S; Zhang, Q | 1 |
Hart, RJ; Mourad, SM; Tang, H; Wang, A; Zhai, SD | 1 |
Čehić, E; Franulić, D; Grgić, F; Kasum, M; Lila, A; Orešković, S; Vujić, G | 1 |
Beketić-Orešković, L; Ježek, D; Kasum, M; Orešković, S; Pekez, M; Stanić, P; Vrčić, H | 1 |
Hart, RJ; Mourad, S; Tang, H; Zhai, SD | 1 |
Haidbauer, R; Murtinger, M; Spitzer, D; Wogatzky, J; Zech, MH; Zech, NH | 1 |
Wiwanitkit, V | 2 |
Baracat, EC; Beltrame, AL; Motta, EL; Serafini, P; Soares Júnior, JM | 1 |
Ando, H; Fukugaki, H; Matsuzawa, K; Mizutani, S; Murata, Y; Nagasaka, T; Saito, K; Takahashi, I | 1 |
4 review(s) available for bromocriptine and Ovarian Hyperstimulation Syndrome
Article | Year |
---|---|
Dopamine agonists for preventing ovarian hyperstimulation syndrome.
Topics: Abortion, Spontaneous; Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Fertilization in Vitro; Humans; Live Birth; Ovarian Hyperstimulation Syndrome; Placebos; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Sperm Injections, Intracytoplasmic | 2021 |
Current Medical Strategies in the Prevention of Ovarian Hyperstimulation Syndrome
Topics: Aminoquinolines; Bromocriptine; Buserelin; Cabergoline; Chorionic Gonadotropin; Dopamine Agonists; Ergolines; Estradiol; Estrogens; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Progesterone; Progestins; Triptorelin Pamoate | 2017 |
Dopamine agonists in prevention of ovarian hyperstimulation syndrome.
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction | 2014 |
Dopamine agonists for preventing ovarian hyperstimulation syndrome.
Topics: Abortion, Spontaneous; Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Reproductive Techniques, Assisted | 2016 |
1 trial(s) available for bromocriptine and Ovarian Hyperstimulation Syndrome
Article | Year |
---|---|
The effects of bromocriptine on VEGF, kidney function and ovarian hyperstimulation syndrome in in vitro fertilization patients: a pilot study.
Topics: Adult; Brazil; Bromocriptine; Dopamine Agonists; Double-Blind Method; Female; Fertilization in Vitro; Glomerular Filtration Rate; Humans; Incidence; Infertility, Female; Kidney; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Patient Dropouts; Pilot Projects; Risk; Severity of Illness Index; Sodium; Vascular Endothelial Growth Factor A | 2013 |
5 other study(ies) available for bromocriptine and Ovarian Hyperstimulation Syndrome
Article | Year |
---|---|
Comparison of bromocriptine and hydroxyethyl starch in the prevention of ovarian hyperstimulation syndrome.
Topics: Bromocriptine; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Retrospective Studies; Starch | 2022 |
Dopamine agonist bromocriptine for the prevention of ovarian hyperstimulation syndrome.
Topics: Adult; Austria; Bromocriptine; Dopamine Agonists; Female; Fertilization in Vitro; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2011 |
Prevention of ovarian hyperstimulation syndrome.
Topics: Bromocriptine; Dopamine Agonists; Female; Fertilization in Vitro; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Risk Factors; Severity of Illness Index; Treatment Outcome | 2011 |
Ovarian hyperstimulation syndrome.
Topics: Adult; Bromocriptine; Female; Gonadotropins; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Research Design; Retrospective Studies | 2011 |
Successful pregnancy after bromocriptine therapy in an anovulatory woman complicated with ovarian hyperstimulation caused by follicle-stimulating hormone-producing plurihormonal pituitary microadenoma.
Topics: Adenoma; Adult; Anovulation; Bromocriptine; Estradiol; Female; Follicle Stimulating Hormone; Follicle Stimulating Hormone, beta Subunit; Humans; Infertility, Female; Magnetic Resonance Imaging; Ovarian Hyperstimulation Syndrome; Pituitary Neoplasms; Pregnancy; Prolactin; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tomography, X-Ray Computed | 2003 |